These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14994922)

  • 41. Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies.
    Catalano A; Iacopetta D; Ceramella J; Scumaci D; Giuzio F; Saturnino C; Aquaro S; Rosano C; Sinicropi MS
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers.
    Zhang L; Ye B; Chen Z; Chen ZS
    Acta Pharm Sin B; 2023 Mar; 13(3):982-997. PubMed ID: 36970215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting Intracellular Calcium Signaling ([Ca
    Büsselberg D; Florea AM
    Cancers (Basel); 2017 May; 9(5):. PubMed ID: 28486397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Claudin-1 silencing increases sensitivity of liver cancer HepG2 cells to 5-fluorouracil by inhibiting autophagy.
    Tong H; Li T; Qiu W; Zhu Z
    Oncol Lett; 2019 Dec; 18(6):5709-5716. PubMed ID: 31788043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An ultrasensitive fluorogenic probe for revealing the role of glutathione in chemotherapy resistance.
    Jiang Y; Cheng J; Yang C; Hu Y; Li J; Han Y; Zang Y; Li X
    Chem Sci; 2017 Dec; 8(12):8012-8018. PubMed ID: 29568448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SIRT6 Depletion Sensitizes Human Hepatoma Cells to Chemotherapeutics by Downregulating MDR1 Expression.
    Xia YQ; Hua RJ; Juan C; Zhong ZH; Tao CS; Fang R; Lin H; Rui G; Yong C
    Front Pharmacol; 2018; 9():194. PubMed ID: 29563873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of CUG-binding protein 1 and activation of caspases are critically involved in piperazine derivative BK10007S induced apoptosis in hepatocellular carcinoma cells.
    Kim JH; Kwon HY; Ryu DH; Nam MH; Shim BS; Kim JH; Lee JY; Kim SH
    PLoS One; 2017; 12(10):e0186490. PubMed ID: 29036189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies.
    Galun D; Srdic-Rajic T; Bogdanovic A; Loncar Z; Zuvela M
    J Hepatocell Carcinoma; 2017; 4():93-103. PubMed ID: 28744453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent.
    Wen L; Liang C; Chen E; Chen W; Liang F; Zhi X; Wei T; Xue F; Li G; Yang Q; Gong W; Feng X; Bai X; Liang T
    Sci Rep; 2016 Mar; 6():23269. PubMed ID: 27011063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms.
    Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
    Cancer Cell Int; 2015; 15():116. PubMed ID: 26692822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual properties of hispidulin: antiproliferative effects on HepG2 cancer cells and selective inhibition of ABCG2 transport activity.
    Scoparo CT; Valdameri G; Worfel PR; Guterres FA; Martinez GR; Winnischofer SM; Di Pietro A; Rocha ME
    Mol Cell Biochem; 2015 Nov; 409(1-2):123-33. PubMed ID: 26209062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells.
    Thewes V; Orso F; Jäger R; Eckert D; Schäfer S; Kirfel G; Garbe S; Taverna D; Schorle H
    BMC Cancer; 2010 May; 10():192. PubMed ID: 20459791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of aqueous extracts of Aconitum carmichaeli, Rhizoma bolbostemmatis, Phytolacca acinosa, Panax notoginseng and Gekko swinhonis Gūenther on Bel-7402 cells.
    Yan ZC; Chen D; Wu XZ; Xie GR; Ba Y; Yan Z
    World J Gastroenterol; 2007 May; 13(19):2743-6. PubMed ID: 17569146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multidrug resistance and its reversal.
    Volm M
    Anticancer Res; 1998; 18(4C):2905-17. PubMed ID: 9713485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [MDR (multidrug resistance) in hepatocarcinoma clinical-therapeutic implications].
    Petraccia L; Onori P; Sferra R; Lucchetta MC; Liberati G; Grassi M; Gaudio E
    Clin Ter; 2003; 154(5):325-35. PubMed ID: 14994922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
    Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.